Relay Therapeutics (RLAY) Payables (2019 - 2026)
Relay Therapeutics (RLAY) posted quarterly Payables of $4.1 million for Q1 2026, down 51.43% year-over-year from $8.4 million in Q1 2025, and down 46.74% quarter-over-quarter from $7.7 million in Q4 2025.
Relay Therapeutics (RLAY) Payables (2019 - 2026) Analysis & Trends
Relay Therapeutics (RLAY) has reported Payables for 8 consecutive years, with $4.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 51.43% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 51.43% YoY), while the FY2025 annual figure was $7.7 million, down 45.34% from the prior year.
- Payables slipped to $4.1 million in Q1 2026 per RLAY's latest filing, from $7.7 million in the prior quarter.
- Across five years, Payables topped out at $14.8 million in Q2 2023 and bottomed at $2.8 million in Q3 2025.
- Historically, Payables has averaged $8.8 million across 5 years, with a median of $8.4 million in 2025.
- Annual changes were most pronounced in 2023 — Payables surged 243.99% — and 2025, when it tumbled 59.92%.
- Relay Therapeutics' Payables stood at $10.6 million in 2022, then fell by 12.92% to $9.2 million in 2023, then jumped by 53.05% to $14.1 million in 2024, then plunged by 45.34% to $7.7 million in 2025, then slumped by 46.74% to $4.1 million in 2026.
- Business Quant data shows RLAY's Payables at $4.1 million in Q1 2026, $7.7 million in Q4 2025, and $2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Relay Therapeutics | 4.34 Bn | 4.34 Bn | - | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.46 Mn |
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 7.71 Mn |
| Sep 30, 2025 | 2.75 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Mar 31, 2025 | 8.45 Mn |
| Dec 31, 2024 | 14.10 Mn |
| Sep 30, 2024 | 6.87 Mn |
| Jun 30, 2024 | 11.17 Mn |
| Mar 31, 2024 | 7.97 Mn |
| Dec 31, 2023 | 9.21 Mn |
| Sep 30, 2023 | 13.35 Mn |
| Jun 30, 2023 | 14.78 Mn |
| Mar 31, 2023 | 11.83 Mn |
| Dec 31, 2022 | 10.58 Mn |
| Sep 30, 2022 | 9.49 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 8.28 Mn |
| Sep 30, 2021 | 6.32 Mn |